Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable tech tracks stress during ketamine therapy for PTSD

NCT ID NCT07614581

Knowledge-focused Sponsor: Adriaan Dirk van der Wart Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a wrist-worn biosensor can detect changes in the body's stress response during ketamine-assisted therapy for PTSD. Five adults will wear the device before, during, and after therapy sessions. The goal is to see if a specific pattern of nervous system activity can be identified, not to measure treatment success.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What could go wrong
This is a very small pilot study with only 2-6 people. It does not test any treatment or health outcome, so it may not lead to any practical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 5 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults aged 19 years or older with a current or previous diagnosis of post-traumatic stress disorder confirmed by CAPS-5 clinical assessment (score 23 or higher), who have independently arranged a ketamine-assisted therapy session with a licensed physician or nurse practitioner in British Columbia, Canada. Participants are recruited through referrals from licensed ketamine-assisted therapy providers in British Columbia. This is a non-probability convenience sample consistent with the pilot and signal characterisation purpose of the study. No healthy volunteers are enrolled.

Ages

19 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adults aged 19 to 65 years 2. Currently enrolled in or referred for equine-assisted therapy at the study facility 3. No prior relationship with the therapy horse assigned to their study sessions 4. Able to wear a chest-strap heart rate monitor comfortably for 35 minutes 5. Able to provide written informed consent in English 6. Willing to have sessions video recorded for research purposes Exclusion Criteria: 1. Diagnosed cardiac arrhythmia of any type 2. Implanted cardiac device including pacemaker or implantable cardioverter-defibrillator 3. Current use of beta-blockers, calcium channel blockers, digoxin, or any other medication known to suppress or significantly alter heart rate variability 4. Active psychosis or acute psychiatric crisis at time of enrolment 5. Inability to provide written informed consent 6. Pregnancy 7. Prior participation in this study under a different horse pairing

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-traumatic stress disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post-traumatic stress disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Open Medicine Studio

    Ganges, British Columbia, V8K 1R1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.